Search results for "Coma"

showing 10 items of 1084 documents

Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment

2003

The effects of combined and simultaneously applied localised 43 degrees C hyperthermia (HT) and an antivascular bacteriochlorophyll-serine-based photodynamic therapy (Bchl-ser-PDT) on tumour growth and several microenvironmental parameters were examined. Rats bearing DS-sarcomas were allocated to treatment groups: (i) sham-treatment (control), (ii) Bchl-ser-PDT (20 mg kg(-1) i.v.), (iii) localised HT, (iv) Bchl-ser-PDT+HT. The light source used was an infrared-A irradiator, which, by use of appropriate filters, delivered the different ranges of wavelengths required. Following treatment, tumour volume was monitored. The greatest tumour growth inhibition was seen with Bchl-ser-PDT+HT, and sub…

MaleHyperthermiaCancer ResearchPathologymedicine.medical_specialtymedicine.medical_treatmentAngiogenesis InhibitorsPhotodynamic therapyOxidative phosphorylationBiologyPharmacologyRats Sprague-DawleyNeovascularizationchemistry.chemical_compoundmedicineAnimalsblood flowCombined Modality TherapyGlycolysisExperimental TherapeuticBacteriochlorophyllsPhotosensitizing AgentsNeovascularization PathologicbacteriochlorophyllHyperthermia InducedOxygenationhyperthermiamedicine.diseaseCombined Modality TherapyCell Hypoxiametabolic statusRatsPhotochemotherapyphotodynamic therapyOncologychemistryModels AnimalSarcoma ExperimentaloxygenationGrowth inhibitionmedicine.symptomCell DivisionBritish Journal of Cancer
researchProduct

Modeling human osteosarcoma in mice through 3AB‐OS cancer stem cell xenografts

2012

Osteosarcoma is the second leading cause of cancer-related death for children and young adults. In this study, we have subcutaneously injected—with and without matrigel—athymic mice (Fox1nu/nu) with human osteosarcoma 3AB-OS pluripotent cancer stem cells (CSCs), which we previously isolated from human osteosarcoma MG63 cells. Engrafted 3AB-OS cells were highly tumorigenic and matrigel greatly accelerated both tumor engraftment and growth rate. 3AB-OS CSC xenografts lacked crucial regulators of beta-catenin levels (E-cadherin, APC, and GSK-3beta), and crucial factors to restrain proliferation, resulting therefore in a strong proliferation potential. During the first weeks of engraftment 3AB-…

MaleIntegrin beta ChainsXENOGRAFTNudeAnimals; Bone Neoplasms; Collagen; Drug Combinations; Focal Adhesion Kinase 1; Gene Expression Regulation Neoplastic; Humans; Injections Subcutaneous; Integrin beta Chains; Laminin; Male; Mice; Mice Nude; Neoplasm Transplantation; Neoplastic Stem Cells; Osteosarcoma; Pluripotent Stem Cells; Proteoglycans; Proto-Oncogene Proteins c-akt; Signal Transduction; Transplantation Heterologous; Tumor Markers Biological3AB-OS CSCSBiochemistryMiceInduced pluripotent stem cellTumor MarkersOsteosarcomaHeterologousSubcutaneousXIAPGene Expression Regulation NeoplasticDrug CombinationsANIMAL MODELSNeoplastic Stem CellsOsteosarcomaProteoglycansCollagenMATRIGELSignal TransductionPluripotent Stem CellsInjections SubcutaneousTransplantation HeterologousMice NudeBone NeoplasmsBiologyInjectionsCyclin D2Cancer stem cellBiomarkers TumormedicineAnimalsHumansMolecular BiologyProtein kinase BNeoplasticTransplantationMatrigelMesenchymal stem cellCell BiologyBiologicalmedicine.disease3AB-OS CSCS; OSTEOSARCOMA; XENOGRAFT; MATRIGEL; ANIMAL MODELSGene Expression RegulationFocal Adhesion Kinase 1ImmunologyCancer researchLamininProto-Oncogene Proteins c-aktNeoplasm TransplantationJournal of Cellular Biochemistry
researchProduct

Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU): an international, prospective observat…

2021

Background: The indications for intracranial pressure (ICP) monitoring in patients with acute brain injury and the effects of ICP on patients’ outcomes are uncertain. The aims of this study were to describe current ICP monitoring practises for patients with acute brain injury at centres around the world and to assess variations in indications for ICP monitoring and interventions, and their association with long-term patient outcomes. Methods: We did a prospective, observational cohort study at 146 intensive care units (ICUs) in 42 countries. We assessed for eligibility all patients aged 18 years or older who were admitted to the ICU with either acute brain injury due to primary haemorrhagic…

MaleIntracranial PressureGlasgow Outcome ScaleMalalties cerebralsintensive care unitlaw.inventionCohort Studies0302 clinical medicinelawBrain Injuries TraumaticMedicineacute brain injuryProspective StudiesProspective cohort studyUnitats de cures intensivesIntracranial pressureIntensive care unitsGlasgow Outcome ScaleMiddle AgedIntensive care unitIntensive Care UnitsHypertensionIntracranial pressure monitoringFemaleHipertensióBrain diseasesAdultmedicine.medical_specialtyCritical CareTraumatic brain injuryIntracranial pressure monitoring brain injury03 medical and health sciencesInternal medicineIntensive careSettore MED/41 - ANESTESIOLOGIAHumansGlasgow Coma ScaleAgedMonitoring Physiologicbusiness.industryGlasgow Coma Scale030208 emergency & critical care medicineICPIntracranial pressure monitoringmedicine.diseaseBrain InjuriesNeurology (clinical)Intracranial Hypertensionbusiness030217 neurology & neurosurgery
researchProduct

The Evonik-Mainz Eye Care-Study (EMECS): Development of an Expert System for Glaucoma Risk Detection in a Working Population

2015

Purpose To develop an expert system for glaucoma screening in a working population based on a human expert procedure using images of optic nerve head (ONH), visual field (frequency doubling technology, FDT) and intraocular pressure (IOP). Methods 4167 of 13037 (32%) employees between 40 and 65 years of Evonik Industries were screened. An experienced glaucoma expert (JW) assessed papilla parameters and evaluated all individual screening results. His classification into “no glaucoma”, “possible glaucoma” and “probable glaucoma” was defined as “gold standard”. A screening model was developed which was tested versus the gold-standard. This model took into account the assessment of the ONH. Valu…

MaleIntraocular pressureEye Diseasesgenetic structuresOptic disklcsh:MedicineGlaucomacomputer.software_genreNerve Fibers0302 clinical medicineCost of IllnessRisk FactorsAnimal CellsOdds RatioPrevalenceMedicine and Health SciencesMedicine030212 general & internal medicinelcsh:ScienceNeuronsMultidisciplinaryPharmaceuticsApplied MathematicsSimulation and ModelingMiddle AgedVisual fieldPhysical SciencesFemaleAnatomyCellular TypesAlgorithmsResearch ArticleAdultmedicine.medical_specialtyOptic DiskResearch and Analysis MethodsSensitivity and SpecificityDiagnosis DifferentialTonometry Ocular03 medical and health sciencesDrug TherapyOcular SystemOphthalmologyHumansWorking populationIntraocular PressureAgedbusiness.industrylcsh:RBiology and Life SciencesGlaucomaOptic NerveCell BiologyOdds ratioGold standard (test)medicine.diseaseeye diseasesExpert systemOphthalmologyCellular Neuroscience030221 ophthalmology & optometryVisual Field TestsEyesOptometrylcsh:Qsense organsVisual FieldsbusinessHeadcomputerMathematicsNeurosciencePLOS ONE
researchProduct

A New Method for Revision of Encapsulated Blebs after Trabeculectomy: Combination of Standard Bleb Needling with Transconjunctival Scleral Flap Sutur…

2016

Purpose A simple needling procedure is the standard method for restoring the function of an encapsulated bleb after trabeculectomy. However, postoperative hypotony represents a possible hazard. This study describes a new surgical approach for treating encapsulated blebs with reduced risk of early postoperative hypotony: bleb needling combined with transconjunctival sutures tightening the scleral flap directly. Methods The study included two groups of 23 patients with failing bleb following trabeculectomy: “Group 1” underwent simple needling revision of the filtering bleb and served as a control group, while “Group 2” received needling revision with additional transconjunctival scleral flap …

MaleIntraocular pressureEye Diseasesgenetic structuresmedicine.medical_treatmentlcsh:MedicineGlaucomaOcular HypotensionPathology and Laboratory MedicineVascular MedicineSurgical FlapsCorneaBlisterPostoperative Complications0302 clinical medicineMedicine and Health SciencesGlaucoma surgeryTrabeculectomylcsh:ScienceDry needlingMultidisciplinaryOphthalmic ProceduresMiddle AgedScleramedicine.anatomical_structureFemaleAnatomyScleraResearch Articlemedicine.medical_specialtyOcular AnatomySurgical and Invasive Medical ProceduresHemorrhageTrabeculectomy03 medical and health sciencesSigns and SymptomsMusculoskeletal System ProceduresAdverse ReactionsOcular SystemDiagnostic MedicineOphthalmologymedicineHumansBleb (cell biology)Intraocular PressureAgedOcular HypotensionPharmacologybusiness.industrylcsh:RBiology and Life SciencesGlaucomamedicine.diseaseeye diseasesSurgeryOphthalmology030221 ophthalmology & optometrylcsh:Qsense organsbusiness030217 neurology & neurosurgeryPLOS ONE
researchProduct

Meta-Analysis of Articles Evaluating Routine Intraocular Pressure Control in Monotherapy in the United States and Germany

2009

Pur P ose . To evaluate routine intraocular pressure (IOP) control in monotherapy patients in the United States and Germany. Methods . Meta-analysis of published articles. We included articles that were prospective studies of ocular hypotensive therapies that measured an unaltered (visit 1) IOP on monotherapy before enrolling into a clinical trial. results . This meta-analysis included 5 studies with 7913 patients, of whom 3245 were from the United States (n=1) and 4668 were from Germany (n=4). In the United States, 2939 patients (91%), and in Germany, 4059 patients (87%), had glaucoma (p<0.0001). Of these, all the US patients (100%) and 2694 (58%) of those from Germany were treated with mo…

MaleIntraocular pressurePediatricsmedicine.medical_specialtyGlaucomaTreatment goals03 medical and health sciences0302 clinical medicineGermanymedicineHumansProspective cohort studyAntihypertensive AgentsIntraocular PressureAgedbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseUnited StatesClinical trialOphthalmologyMeta-analysisLower pressure030221 ophthalmology & optometryFemaleOcular HypertensionbusinessGlaucoma Open-Angle030217 neurology & neurosurgeryEuropean Journal of Ophthalmology
researchProduct

Influence of Corneal Opacity on Intraocular Pressure Assessment in Patients with Lysosomal Storage Diseases

2017

Aims To investigate an influence of mucopolysaccharidosis (MPS)- and Morbus Fabry-associated corneal opacities on intraocular pressure (IOP) measurements and to evaluate the concordance of the different tonometry methods. Methods 25 MPS patients with or without corneal clouding, 25 Fabry patients with cornea verticillata ≥ grade 2 and 25 healthy age matched controls were prospectively included into this study. Outcome measures: Goldmann applanation tonometry (GAT); palpatory assessment of IOP; Goldmann-correlated intraocular pressure (IOPg), corneal-compensated intraocular pressure (IOPcc), corneal resistance factor (CRF) and corneal hysteresis (CH) assessed by Ocular Response Analyzer (ORA…

MaleIntraocular pressureVisual acuityEye Diseasesgenetic structuresVisionVisual AcuitySocial Scienceslcsh:MedicineGlaucomaCorneaCorneal Opacity0302 clinical medicineCorneaMedicine and Health SciencesPsychologyCornea verticillatalcsh:ScienceOptical PropertiesMultidisciplinaryCorneal opacityMiddle Agedmedicine.anatomical_structurePhysical SciencesSensory PerceptionFemaleAnatomyCellular Structures and Organellesmedicine.symptomStatistics (Mathematics)Research ArticleOpacityAdultmedicine.medical_specialtyAdolescentOcular AnatomyMaterials ScienceMaterial PropertiesCorneal hysteresis03 medical and health sciencesOcular SystemOphthalmologyConfidence IntervalsmedicineHumansIn patientIntraocular PressureAgedbusiness.industrylcsh:RBiology and Life SciencesGlaucomaCell BiologyMucopolysaccharidosesmedicine.diseaseeye diseasesOphthalmology030221 ophthalmology & optometryEyeslcsh:Qsense organsLysosomesbusinessHeadMathematics030217 neurology & neurosurgeryNeurosciencePLOS ONE
researchProduct

A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma

2014

Purpose To assess the safety and effectiveness of the Hydrus Microstent (Ivantis, Inc, Irvine, CA) with concurrent cataract surgery (CS) for reducing intraocular pressure (IOP) in open-angle glaucoma (OAG). Design Prospective, multicenter, randomized, single-masked, controlled clinical trial. Participants One hundred eyes from 100 patients 21 to 80 years of age with OAG and cataract with IOP of 24 mmHg or less with 4 or fewer hypotensive medications and a washed-out diurnal IOP (DIOP) of 21 to 36 mmHg. Methods On the day of surgery, patients were randomized 1:1 to undergo CS with the microstent or CS alone. Postoperative follow-up was at 1 day, 1 week, and 1, 3, 6, 12, 18, and 24 months. Wa…

MaleIntraocular pressureVisual acuityMinimally invasive glaucoma surgerymedicine.medical_treatmentVisual AcuityGlaucomalaw.inventionRandomized controlled trialLens Implantation Intraocularlaw80 and overMedicineSingle-Blind MethodProspective StudiesProspective cohort studyGlaucoma Drainage ImplantsAged 80 and overIntraocularMedicine (all)Adult; Aged; Aged 80 and over; Antihypertensive Agents; Female; Follow-Up Studies; Glaucoma Open-Angle; Humans; Intraocular Pressure; Lens Implantation Intraocular; Limbus Corneae; Male; Middle Aged; Prospective Studies; Prosthesis Implantation; Single-Blind Method; Tonometry Ocular; Visual Acuity; Visual Fields; Young Adult; Glaucoma Drainage Implants; Phacoemulsification; Stents; Ophthalmology; Medicine (all)Middle AgedOpen-AngleFemaleStentsmedicine.symptomLens ImplantationGlaucoma Open-AngleAdultmedicine.medical_specialtyLimbus CorneaeTonometryProsthesis ImplantationTonometry OcularYoung AdultOphthalmologyOcularHumansAntihypertensive AgentsIntraocular PressureAgedPhacoemulsificationbusiness.industryGlaucomaPhacoemulsificationCataract surgerymedicine.diseaseOphthalmologyVisual FieldsbusinessFollow-Up Studies
researchProduct

The Heidelberg retina tomograph ancillary study to the European glaucoma prevention study: study design and baseline factors.

2013

Purpose: To describe the study design and baseline factors of the Heidelberg Retina Tomograph ancillary study within the EGPS. Furthermore, to examine the relationship between HRT optic disc topographic measurements and baseline demographic and ocular factors. Methods: Four hundred and eighty-nine ocular hypertensive participants were included. Each participant completed HRT imaging at least annually. The associations between HRT measurements and IOP, central corneal thickness (CCT), baseline photographic estimates of vertical CDR ratio (CDR), asymmetry between the two eyes in CDR ratio and baseline visual field indices were assessed using regression analysis. Results: Associations between …

MaleIntraocular pressureVisual acuitygenetic structuresOptic diskVisual AcuityOcular hypertensionGlaucomaOptic Nerve DiseasesMedicineHRT parameterCarbonic Anhydrase Inhibitorspattern standard deviationTomographySulfonamidesmedicine.diagnostic_testGeneral MedicineMiddle Agedmedicine.anatomical_structureResearch DesignOptic nerveFemalemedicine.symptomHumanOptic discmedicine.medical_specialtyCarbonic Anhydrase Inhibitorscanning laser ophthalmoscopyOptic DiskVisual FieldThiophenesSulfonamideOphthalmoscopyTonometry OcularOptic Nerve DiseaseDouble-Blind MethodThiopheneOphthalmologymental disordersHumansIntraocular Pressurebusiness.industryGlaucomamedicine.diseaseeye diseasesOphthalmoscopyOphthalmologyOcular Hypertensionsense organsVisual Fieldsbusinesscentral corneal thickneActa ophthalmologica
researchProduct

Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up.

2015

Background Clinical studies comparing trabeculectomy augmented with Ologen implant (OLO) versus trabeculectomy plus mitomycin-C (MMC) show contradictory results. To obtain long-term data, we report an extended 5-year follow-up trial evaluating the safety and efficacy of OLO as adjuvant compared to low-dosage MMC in trabeculectomy. Methods Forty glaucoma patients (40 eyes) assigned to trabeculectomy with MMC or Ologen. Primary outcome: target IOP at ≤21, ≤17 and ≤15 mmHg; complete and qualified success endpoint rates. Secondary outcomes: visual acuity (VA), mean deviation (MD), bleb evaluation, according to Moorfields Bleb Grading System (MBGS); spectral domain OCT (SD-OCT) bleb examination;…

MaleIntraocular pressureVisual acuitygenetic structuresmedicine.medical_treatmentVisual AcuityGlaucomaExfoliation Syndrome0302 clinical medicineAbsorbable ImplantsTrabeculectomyExtended 5-yrs follow-upExtended 5-yrs follow-up; Mitomycin-C; Ologen; Trabeculectomy;GlycosaminoglycansGeneral MedicineMiddle AgedMitomycin-CFemaleCollagenmedicine.symptomGlaucoma Open-AngleTomography Optical CoherenceHumanResearch ArticleAdultmedicine.medical_specialtyAlkylating AgentsMitomycinTrabeculectomyOlogenFollow-Up Studie03 medical and health sciencesAbsorbable ImplantOphthalmologymedicineHumansIntraocular PressureAgedSettore MED/30 - Malattie Apparato Visivobusiness.industryMitomycin CFive year follow upANTIGLAUCOMA MEDICATIONSAlkylating Agentmedicine.diseaseeye diseasesSurgeryOphthalmologyGlycosaminoglycan030221 ophthalmology & optometryImplantsense organsbusiness030217 neurology & neurosurgeryFollow-Up StudiesBMC ophthalmology
researchProduct